A US-based discrete choice experiment survey found that patients with atopic dermatitis (AD) prioritize treatments that effectively control itching. Because of the differences in health care and ...

These new atopic dermatitis (AD) treatment guidelines from the American Academy of Dermatology (AAD) update their 2014 recommendations for the management of AD with phototherapy and systemic therapies ...

Please provide your email address to receive an email when new articles are posted on . Zoryve cream 0.05% is a nonsteroidal, phosphodiesterase 4 inhibitor that has shown efficacy in clinical trials.

Please provide your email address to receive an email when new articles are posted on . EASI 75 and validated IGA-AD 0/1 response rates from week 16 were maintained through week 140. No new safety ...

Kymera Therapeutics, Inc. (KYMR) just reported positive results from its phase 1 healthy volunteer study using KT-621. The purpose of this clinical candidate is to develop it as an oral STAT6 protein ...